📰 Epic Pharma News
Page 4 - Epic Pharma News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Epic Pharma. Real-time updates on events, politics, business and more.
October 14, 2022
The U.S. is suffering a shortage of amphetamine mixed salts, an active ingredient used to treat attention deficit hyperactivity disorder and narcolepsy, warned the Food and Drug Administration.
October 14, 2022
2022’s Adderall shortage has been going on since the summer. The FDA finally made it official.
October 14, 2022
The U.S. is suffering a shortage of amphetamine mixed salts, an active ingredient used to treat attention deficit hyperactivity disorder and narcolepsy, warned the Food and Drug Administration.
October 13, 2022
The Food and Drug Administration (FDA) finally acknowledged the problem following months of anecdotal reports of desperate patients rationing doses.
June 29, 2022
NORTHVALE, NJ / ACCESSWIRE / June 29, 2022 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, today announced that
June 29, 2022
Conference Call Scheduled for Thursday, June 30 at 11:30 AM EDTNORTHVALE, NJ / ACCESSWIRE / June 29, 2022 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical
June 23, 2022
Financials for Fiscal Year 2022 Ended March 31, 2022 will be released on June 29, 2022NORTHVALE, NJ / ACCESSWIRE / June 23, 2022 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a
February 15, 2022
15.02.2022 - Conference Call Scheduled for Tuesday, February 15 at 11:30 AM ESTNORTHVALE, NJ / ACCESSWIRE / February 14, 2022 / Elite Pharmaceuticals, Inc. (Elite or the Company)(OTCQB:ELTP), a specialty pharmaceutical company developing niche generic ...
January 28, 2022
/PRNewswire/ -- According to Coherent Market Insights, the global addiction treatment market is estimated to be valued at US$ 8,297.0 million in 2021 and is...
January 28, 2022
/PRNewswire/ -- According to Coherent Market Insights, the global addiction treatment market is estimated to be valued at US$ 8,297.0 million in 2021 and is...